Infusion Systems

Global Infusion Systems Market to Reach US$63.7 Billion by 2030

The global market for Infusion Systems estimated at US$44.4 Billion in the year 2024, is expected to reach US$63.7 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Infusion Pumps, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$36.4 Billion by the end of the analysis period. Growth in the Consumables segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.0 Billion While China is Forecast to Grow at 10.1% CAGR

The Infusion Systems market in the U.S. is estimated at US$12.0 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$13.8 Billion by the year 2030 trailing a CAGR of 10.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Infusion Systems Market - Key Trends and Drivers Summarized

How Are Infusion Systems Revolutionizing Medical Treatment and Patient Care?

Infusion systems are revolutionizing medical treatment and patient care by providing precise, controlled delivery of medications, nutrients, and fluids directly into a patient`s bloodstream. These systems, which include devices like infusion pumps, intravenous (IV) lines, and associated software, are critical in a wide range of medical settings, from hospitals and clinics to home healthcare. Infusion systems enable the continuous and accurate administration of drugs over extended periods, which is essential for treatments such as chemotherapy, pain management, hydration therapy, and antibiotic delivery. The ability to precisely control the dosage and timing of medication delivery not only improves therapeutic outcomes but also reduces the risk of human error and adverse drug reactions. This precision is particularly important in critical care and for patients with chronic conditions who require consistent and reliable treatment, making infusion systems indispensable in modern healthcare.

What Innovations Are Enhancing the Functionality of Infusion Systems?

Innovations in infusion systems are enhancing their functionality through advancements in automation, connectivity, and patient safety features. Modern infusion pumps are increasingly equipped with smart technology, allowing for integration with hospital electronic health record (EHR) systems. This connectivity enables automated data entry, reducing the likelihood of manual errors and ensuring that infusion parameters are accurately followed. Additionally, many infusion systems now include dose error reduction systems (DERS) that alert healthcare providers to potential dosing errors, enhancing patient safety. Wireless connectivity and remote monitoring capabilities are also becoming standard, allowing healthcare professionals to track and adjust infusion therapy in real time, even from a distance. Furthermore, the development of portable and wearable infusion devices is making it easier for patients to receive continuous care outside of traditional healthcare settings, improving their quality of life by enabling mobility and independence. These innovations are making infusion systems more reliable, safer, and adaptable to various clinical needs.

How Do Infusion Systems Impact Patient Outcomes and Healthcare Efficiency?

Infusion systems have a profound impact on patient outcomes and healthcare efficiency by enabling more consistent and effective treatment, reducing the incidence of complications, and streamlining care processes. The precise delivery of medication and fluids through infusion systems ensures that patients receive the correct dosage at the right time, which is crucial for managing complex medical conditions. This precision reduces the risk of complications such as overdose, underdose, or medication interactions, thereby improving overall patient safety. In terms of healthcare efficiency, infusion systems reduce the need for manual intervention by automating much of the medication delivery process. This automation frees up healthcare providers to focus on other critical aspects of patient care, leading to more efficient use of time and resources. Additionally, the integration of infusion systems with digital health records and remote monitoring tools allows for better coordination of care, ensuring that treatment protocols are followed accurately and that any issues are quickly identified and addressed.

What Trends Are Driving Growth in the Infusion Systems Market?

Several trends are driving growth in the infusion systems market, including the increasing prevalence of chronic diseases, the rise of home healthcare, and advancements in medical technology. As the global population ages and the incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases rises, the demand for reliable and efficient infusion systems continues to grow. These systems are essential for the long-term management of chronic diseases, where continuous or frequent medication delivery is required. The shift towards home healthcare is also fueling market growth, as more patients seek to receive care in the comfort of their homes rather than in hospitals. Portable and wearable infusion systems, designed for home use, are becoming increasingly popular as they allow patients to maintain their normal routines while receiving necessary treatments. Additionally, advancements in medical technology, such as the integration of artificial intelligence (AI) and machine learning into infusion systems, are enhancing the capabilities and safety of these devices. These trends underscore the expanding role of infusion systems in modern healthcare, where they are essential for improving patient outcomes and optimizing care delivery across various settings.

SCOPE OF STUDY:

The report analyzes the Infusion Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Infusion Pumps, Consumables, Accessories); End-Use (Hospitals, Clinics & Ambulatory Surgery Centers, Homecare Settings)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 36 Featured) -

• Avanos Medical, Inc.
• B. Braun Melsungen AG
• Baxter International, Inc.
• Becton, Dickinson and Company
• Fresenius Kabi AG
• ICU Medical, Inc.
• JMS North America Corporation
• Medtronic, Inc.
• Micrel Medical Devices SA
• Nipro Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.